Mammography screening: Swedish study in The Lancet confirms the effectiveness of Artificial Intelligence
The final results of the MASAI study, published in The Lancet and covered by major international media outlets such as The Guardian, mark a turning point in oncological diagnostics. The randomized trial, involving over 100,000 women in Sweden, demonstrates that integrating AI into the screening workflow is not only safe, but superior to traditional methods. […]
Prostate cancer diagnosis: Health Triage in Florence for the Tuscan GOM network meeting.
On March 26–27, 2026, Health Triage will participate as a sponsor in the course “Diagnosis, Staging and Multidisciplinary Management of Prostate Cancer: The Tuscan GOM Network in Action.” The event, which will take place at the Grand Hotel Mediterraneo in Florence, represents a strategic opportunity for discussion among coordinators of regional oncology networks, aimed at […]
Breast screening and AI: Francesca Caumo (GISMa) explains the value of the Breast AI study in La Repubblica
Artificial Intelligence is entering the core of organized mammographic screening. In La Repubblica, within the Health special section, Dr. Francesca Caumo, Vice President of GISMa (Italian Group for Mammographic Screening), discusses the challenges and opportunities related to integrating new technologies into prevention pathways. At the center is the large prospective multicenter study, Breast AI, born […]
Screening senologico e IA: Francesca Caumo (GISMa) illustra su “La Repubblica” il valore dello studio Breast AI
L’Intelligenza Artificiale entra nel vivo dello screening mammografico organizzato. Su La Repubblica, all’interno dello speciale Salute, la dott.ssa Francesca Caumo, Vice presidente del GISMa (Gruppo Italiano Screening Mammografico), approfondisce le sfide e le opportunità legate all’integrazione delle nuove tecnologie nei percorsi di prevenzione. Al centro il grande studio prospettico multicentrico, Breast.Ai, nato dalla collaborazione tra il GISMa e Health Triage, volto a validare soluzioni di IA capaci […]
Breast screening: partnership between the Italian Mammography Screening Group (GISMa) and Health Triage for one of the most innovative European studies on the use of Artificial Intelligence
An agreement has been signed for a clinical validation study involving 75,000 women: the goal is to strengthen the national prevention programme through “intelligent triage”, which optimises radiologists’ work and accelerates diagnoses. TURIN, 12 February 2026 – With the introduction of new guidelines on AI applied to prevention at the end of 2025, Italy strengthens […]
Screening senologico: alleanza tra Gruppo Italiano Screening Mammografico (GISMa) e Health Triage per uno dei più innovativi studi europei sull’uso dell’Intelligenza Artificiale
Siglato l’accordo per la validazione clinica su 75.000 donne: l’obiettivo è potenziare la prevenzione nazionale attraverso il “triage intelligente” che ottimizza il lavoro dei radiologi e accelera le diagnosi. TORINO 12 febbraio 2026 – Con l’introduzione delle nuove linee guida sull’IA applicata alla prevenzione a fine 2025, l’Italia rafforza il proprio ruolo nel panorama europeo della lotta al […]
The (Digital) Silk Road: What China’s Healthcare AI Boom Teaches Western Medicine
In China, artificial intelligence is no longer asking permission to enter hospitals: it already has the keys. A recent report by Rest of World describes a rapidly expanding ecosystem led by Ant Group, where healthcare AI has become an integral part of accessing care. At the center of this system is Ant Afu, a chatbot […]
Breast Cancer Prevention with AI: Health Triage Featured in the New Spin-off of “Artificial Intelligence Explained Simply”
Breast cancer, thanks to the effectiveness of prevention programs, is the most diagnosed cancer worldwide. However, it still remains the leading cause of cancer-related death among women. Artificial Intelligence has already entered the healthcare sector, driven by the expertise and determination of many Italian professionals. This is the focus of “My Health”, the new spin-off […]
Screening mammografico: lo studio svedese su The Lancet conferma l’efficacia dell’Intelligenza Artificiale
I risultati definitivi dello studio MASAI, pubblicati sulla rivista The Lancet e ripresi dalle principali testate internazionali come The Guardian, segnano una svolta nel campo della diagnostica oncologica. Il trial randomizzato, che ha coinvolto oltre centomila donne in Svezia, dimostra che l’integrazione dell’IA nel workflow di screening non solo è sicura, ma superiore ai metodi tradizionali. Secondo le evidenze […]
Mammography Screening and AI: Health Triage Presents the BreastNegative Experience at GISMa 2026
Health Triage will be present at the National Congress of GISMa (Gruppo Italiano Screening Mammografico – Italian Mammography Screening Group), scheduled at the AURUM in Pescara from May 20 to 22, 2026. The event is the main national reference point for public health dedicated to breast cancer prevention, and this year will focus on the […]
